CBD shows promise for traumatic brain injury recovery in small trial
NCT ID NCT05632627
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether cannabidiol (CBD) can improve thinking, mood, and other symptoms in people who have had a traumatic brain injury (TBI). 43 adults with mild or moderate TBI took either CBD or a placebo for 12 weeks. Researchers measured changes in cognition, neuropsychiatric symptoms, and inflammation markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cannabidiol (CBD)
What this could lead to
If it works, CBD could become a treatment option for lingering symptoms like memory problems, anxiety, and pain after a traumatic brain injury.
What could go wrong
This is a small, early-phase trial with only 43 people. The results may not apply to everyone, and CBD might not work better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN INJURIES, TRAUMATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Anschutz
Aurora, Colorado, 80045, United States